{"id":"https://openalex.org/W2243880667","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.564","title":"Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer","display_name":"Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2243880667","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.564","mag":"2243880667"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.564","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.564","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.564","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2243880667"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113710951","display_name":"J. T. Carpenter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. T. Carpenter","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052648400","display_name":"Henri Hubert Roche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Roch\u00e9","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071553983","display_name":"Mario Campone","orcid":"https://orcid.org/0000-0002-5196-5908","observed_orcids":["https://orcid.org/0000-0002-5196-5908"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Campone","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047280933","display_name":"R\u00e1m\u00f3n Colomer","orcid":"https://orcid.org/0000-0002-6393-3444","observed_orcids":["https://orcid.org/0000-0002-6393-3444"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Colomer","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069626166","display_name":"Agnieszka Jagie\u0142\u0142o-Gruszfeld","orcid":"https://orcid.org/0000-0002-2698-5499","observed_orcids":["https://orcid.org/0000-0002-2698-5499"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Jagiello-Gruszfeld","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Moore","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. D\u2019Amore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. D\u2019Amore","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090141367","display_name":"Sun\u2010Young Kong","orcid":"https://orcid.org/0000-0003-0620-4058","observed_orcids":["https://orcid.org/0000-0003-0620-4058"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Kong","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017509777","display_name":"Joseph P Boni","orcid":"https://orcid.org/0000-0003-0228-0213","observed_orcids":["https://orcid.org/0000-0003-0228-0213"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Boni","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["ES","FR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Baselga","raw_affiliation_strings":["Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France; Inst Catala d\u2019Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210107147","https://openalex.org/I4210128666","https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"564","last_page":"564"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.03460000082850456,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.996999979019165},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9079999923706055},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.8740000128746033},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.9539999961853027},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/intermittent-dosing","display_name":"intermittent dosing","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5809999704360962},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8100000023841858},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6710000038146973},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.38499999046325684},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.47999998927116394},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.5609999895095825},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.33399999141693115},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.4569999873638153},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.923762857913971},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.9044064283370972},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.6928313970565796},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5814128518104553},{"id":"https://openalex.org/C2777482430","wikidata":"https://www.wikidata.org/wiki/Q7168709","display_name":"Peripheral edema","level":3,"score":0.5386689901351929},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5231519937515259},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4940817654132843},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4935077428817749},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.48402804136276245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4354211091995239},{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.4303673505783081},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3671687841415405},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34142830967903137},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33510327339172363},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3336073160171509},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.21086421608924866},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.10529178380966187},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.05907145142555237},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.564","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.564","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.564","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2257439960","https://openalex.org/W2112001957","https://openalex.org/W1990883066","https://openalex.org/W2586469457","https://openalex.org/W2514999275","https://openalex.org/W2373695127","https://openalex.org/W2150937214","https://openalex.org/W2022765594","https://openalex.org/W2604855606"],"abstract_inverted_index":{"564":[0],"Background:":[1],"Temsirolimus":[2],"(tem,":[3],"CCI-779),":[4],"a":[5,52],"novel":[6],"mTOR":[7],"inhibitor,":[8],"is":[9,349],"well":[10],"tolerated":[11],"and":[12,35,98,109,259,271,288,322],"has":[13,293],"antitumor":[14],"activity":[15,36],"in":[16,40,51,157,201,268],"heavily":[17],"pretreated":[18],"patients":[19],"(pts)":[20],"with":[21,42,46,63,311],"metastatic":[22],"breast":[23],"cancer":[24],"(MBC,":[25],"Proc":[26],"ASCO":[27],"22:193,2003).":[28],"In":[29],"this":[30],"trial,":[31],"we":[32],"evaluate":[33],"safety":[34],"of":[37,115,153,159,197,203,273],"oral":[38],"tem":[39,65,72,92,143],"combination":[41,307,335],"letrozole.":[43],"Methods:":[44],"Patients":[45],"measurable":[47],"MBC":[48],"were":[49,94,103],"randomized":[50],"1:1:1":[53],"ratio":[54],"(\u223c30":[55],"evaluable":[56],"pts/arm):":[57],"1)":[58],"letrozole":[59,62,88,146,187,222,241,298,340],"alone":[60,299,341],"or":[61,70,122,315,355,358],"2)":[64],"daily":[66,68,73,97,108,314],"(tem":[67,80,140],"arm)":[69],"3)":[71],"for":[74,132,296,305,333,338],"5":[75],"days":[76],"every":[77],"2":[78,243],"weeks":[79],"intermittent":[81,101,112,318],"arm).":[82],"All":[83],"pts":[84,117,135,160,204],"received":[85],"2.5":[86],"mg":[87,96,100,107,111,163,173,207,212,230,235,313,317],"daily.":[89],"Results:":[90],"Initially,":[91],"doses":[93],"25":[95],"75":[99],"but":[102,303],"amended":[104],"to":[105,284],"10":[106,114,162,206,229,245,312],"30":[110,172,211,234,316],"because":[113],"12":[116],"had":[118],"dose":[119],"delays,":[120],"reductions,":[121],"discontinuations.":[123],"Data":[124],"collected":[125],"by":[126],"15":[127],"Nov":[128],"2004":[129],"are":[130],"presented":[131],"the":[133,138,297,306,334,339],"92":[134],"enrolled":[136],"after":[137],"amendment":[139],"daily:":[141,164,208,231],"33;":[142],"intermittent:":[144,174,213,236],"30;":[145],"alone:":[147,188,223,242],"29).":[148],"Grade":[149,193],"1\u20134":[150],"toxicities,":[151,195],"regardless":[152,196],"causality,":[154,198],"that":[155,199,328],"occurred":[156,200,264],">30%":[158],"included":[161,205],"asthenia":[165,175,189,216],"(45%),":[166],"mucositis":[167,177],"(42%),":[168],"peripheral":[169],"edema":[170],"(36%);":[171],"(63%),":[176],"(57%),":[178],"arthralgia":[179],"(37%),":[180,182],"anorexia":[181],"diarrhea":[183],"(33%),":[184],"epistaxis":[185],"(33%);":[186],"(52%),":[190],"nausea":[191],"(31%).":[192],"3\u20134":[194],">5%":[202],"hyperglycemia":[209,214],"(9%);":[210],"(17%),":[215],"(7%),":[217,219],"hypertension":[218],"hypokalemia":[220],"(7%);":[221],"none.":[224],"Objective":[225],"responses":[226],"(RECIST)":[227],"occurred,":[228],"9":[232],"PR;":[233,240],"1":[237,280],"CR,":[238,244],"8":[239],"PR.":[246],"Clinical":[247],"benefit":[248],"(CR":[249],"+":[250,252],"PR":[251],"SD":[253],"\u22658":[254],"wks)":[255],"was":[256,282],"82%,":[257],"83%,":[258],"79%,":[260],"respectively.":[261,275,290],"Progressive":[262],"disease":[263],"at":[265,279],"\u22648":[266],"wks":[267],"12%,":[269],"10%,":[270],"14%":[272],"pts,":[274],"Progression-free":[276],"survival":[277],"(PFS)":[278],"yr":[281],"estimated":[283],"be":[285,331],"69%,":[286],"62%,":[287],"48%,":[289],"Median":[291],"PFS":[292,329],"been":[294],"reached":[295],"arm":[300],"(9.2":[301],"mo)":[302],"not":[304],"arms.":[308],"Conclusions:":[309],"Letrozole":[310],"temsirolimus":[319],"showed":[320],"tolerability":[321],"clinical":[323],"activity.":[324],"Early":[325],"data":[326],"suggest":[327],"may":[330],"longer":[332],"arms":[336],"than":[337],"arm.":[342],"An":[343],"actively":[344],"recruiting":[345],"phase":[346],"3":[347],"study":[348],"being":[350],"conducted.":[351],"Author":[352],"Disclosure":[353],"Employment":[354],"Leadership":[356],"Consultant":[357],"Advisory":[359],"Role":[360],"Stock":[361],"Ownership":[362],"Honoraria":[363],"Research":[364],"Funding":[365],"Expert":[366],"Testimony":[367],"Other":[368],"Remuneration":[369],"Wyeth":[370,371,372]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2243880667","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
